Comparison between spirometry and oscillation techniques result before and after gastroesophageal reflux disease treatment

Status

Active, not recruiting

Phases

Phase 2

Study type

Interventional

Source

IRCT

Registry ID

IRCT201102035749N1

Enrollment

Registered

2011-03-15

Start date

2010-06-22

Completion date

Unknown

Last updated

2018-02-22

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Comparison between spirometry and ososcillation techniques. Other chronic obstructive pulmonary disease

Interventions

Omperazole, 40 mg twice a day, for 12 weeks.

Treatment - Drugs

Omperazole, 40 mg twice a day, for 12 weeks

Eligibility

Sex/Gender

All

Age

18 Years to 40 Years

Inclusion criteria

Inclusion criteria: Inclusion criteria: GERD disease confirmed with endoscopy Exclusion criteria: history of chronic heart disease, history of airway disease, pregnancy, smoking, liver disease

Exclusion criteria

Exclusion criteria:

Design outcomes

Primary

Measure	Time frame
Spirometry. Timepoint: before intervention and 3 months after intervention. Method of measurement: PFT.;Oscillometry. Timepoint: before intervention and 3 months after intervention. Method of measurement: PFT.	—

Countries

Iran (Islamic Republic of)

Contacts

Public ContactDr. Masoumeh Hosaini Askarabadi

Ahvaz Jundishapur University of Medical Sciences

hosaini.m@ajums.ac.ir+98 61 1373 8431

Outcome results

None listed

Source: IRCT (via WHO ICTRP) · Data processed: Feb 4, 2026